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Abstract Hypericum perforatum L or St. John's wort is a medicinal plant with long history use
in traditional. Because Romanian and European Pharmacopoeia accept as officinal only H. perforatum
L, the present study compare the characteristics of the H. perforatum and H. maculatum. The
experiment was carried out on 28 white Swiss male mice, for 14 days long; each animal received 106
Ehrlich Ascitic Carcinoma cells i.p., in the day 0. Animals were divided in four equal experimental
groups, First group (HM) received 172 mg/kg b.w. H. maculatum, the second group (HP) 172 mg/kg
b.w. H. perforatum, the control group, and the last group Doxorubicin cloride 2.5 mg/ kg b.w in day 6
of experiment. Both groups HM and HP received intra peritoneal injections in days 1, 4, and 7 of
experiment. White blood cells and the platelets were increase in Hypericum treated groups;
leucocytosis was more evident in H. perforatum, mainly because of the granulocytes. Doxorubicin
prevents the elevation of granulocytes levels, no similar effect was found in Hypericum treated
animals. Even no so effective like Doxorubicin, alcoholic extracts provides a protective effect, but
statistical significance was found only for H. maculatum. In conclusion, both Hypericum sp. (H.
maculatum and H. perforatum), have shown anticancer effect, through inhibition of tumor cells
development and elevating the white blood cells level. This might be the basis of new pharmaceutical
remedies using H.maculatum a wide spread species in mountain regions of Romania.
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INTRODUCTION
Hypericum perforatum L or St. John's wort is a medicinal plant with a long history of
use in traditional medicine all over Europe. In Romania’s spontaneous flora are mentioned 12
species of Hypericum (Stănescu et. al. 2004). The most widely spread, and used species are
H. perforatum L. (in the hills regions) and H. maculatum Crantz. (in the mountain regions)
Tămaş, et. al. (2001); H. maculatum is also harvested in order to obtain Hyperici herb (Ciulei,
et. al. 1993).
Both Romanian Pharmacopoeia (R.Ph. 1993) and European Pharmacopoeia (E. Ph.
2008) accept as officinal only H. perforatum L, therefore the aim of the present study is to
compare the botanical and physiochemical characteristics of the H. perforatum and H.
maculatum, the most widely spread species from Romania.
Aerial parts of Hypericum species contain the following active substances:
naphtodiantrons 0.1-0.5% (hypericin, pseudohypericin and their isomers), flavonoids 4-5%
(hyperoside, rutoside, quercitroside, biapigenin), tannins 10-20%, hyperforin,
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proanthocyanins, caffeic acid derivatives, xanthons, essential oil 0.1-1% etc (Herman, and
Gheorgiu, 1961)
Ehrlich ascitic carcinoma (EAC) is a convenient model for investigation of tumour
proliferation and side effects (Olinescu, 1992). EAC, induce significant plasma biochemical
changes, including antioxidant systems; transplantable tumors have been successfully used to
prove the antioxidant and anti malignant properties for beta carotene (Marcus, et. al. 1998).
Significant antioxidant effects were also provided by Peucedanum oreoselinum even no
obvious antiproliferative effect was found (Sevastre, et al. 2008).
MATERIALS AND METHODS
Plant materials: the aerial parts of H. perforatum were harvested from Chiribiş (Bihor
county) and the aerial parts of H. maculatum were harvested from Ciucea (Cluj county) in the
blossom period. The vegetal products were dried and grounded to a fine powder (sieve VI -
R. Ph. 1993), (Istudor,1998).
Preparation of tinctures: 10g of powdered aerial parts of vegetal product were
extracted with 100g of ethanol 70° at room temperature, as described in Romanian
Pharmacopoeia Xth Edition.
In E. Ph. 2008 it is mentioned as minimum content in total hypericins for the
medicinal drug Hyperici herb 0.08%, determined by a spectrophotometer method and a
qualitative analysis by TLC (York, et. al. 1990) in order to identify the flavonoids and
hypericin.
To prevent toxic effect of the alcohol, often more toxic than plant compounds
dissolved in it, alcoholic solution was maintained in a water bath until 3 / 4 of the content
evaporates, than filed with sterile saline solution to 0.5 ml for each animal. The sterile
solution was administrated in the same day in order to prevent bacterial and fungus
contamination.
To assess the biological effects of substances in study, other 28 animals were subject
of administration of plant extracts, control and Doxorubicin chloride alone in the same doses,
at the same time.
The animals were caged in groups of seven per cage, at controlled temperature of 21-
22ºC, humidity (40-60%) and reversed 12/12h light/dark cycle (light off at 10 a.m.). Standard
lab chow provided by National Institute for Research and Development “Cantacuzino”
Bucharest (Batch no. 2 / 26.03.2010), and water were freely available. The permission for the
animal tests and experiments has been given by the Bioethical Board of the Faculty of
Veterinary Medicine Cluj-Napoca.
For assessing the antiproliferative effect, the experiment was carried out on 28 white
Swiss male mice, 34.5±3.5g body weight; each animal received 106 ascitic cells intra
peritoneal, in the day 0 of the experiment. The experiment last for 14 days, in the Department
of Pathophysiology, University of Agricultural Science and Veterinary Medicine Cluj-
Napoca. Ehrlich Ascitic Carcinoma (EAC) was a generous gift from the Oncology Institute
“I. Chiricuta” Cluj Napoca.
Animals were divided in four equal experimental groups; all inoculated with Ehrlich
Ascitic Carcinoma. Body weight was measured at the beginning, and at the end of
experiment.
First group (HM) received 172 mg/kg b.w., H. maculatum, the second group (HP)
received 172 mg/kg b.w. H. prerforatum. Both groups HM and HP received intra peritoneal
injections in days 1, 4, and 7 of experiment. The control group received only EAC, and the
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last group received intra peritoneal injections with Doxorubicin cloride 2.5 mg/ kg b.w.
(Adriablastina 10 mg – Phizer) in days 1 and 6 of experiment.
In the end the blood was harvested from the retro orbitary sinus under diethyl ether
anesthesia and the euthanasia was made by prolonged ether narcosis. Total amount of ascitic
fluid was measured, and viable tumor cell concentration was counted in a Burker camera
(liquid diluted 1:200). Cell viability was assessed by tripan blue staining (Olinescu, 1992).
Blood haematology was investigated with Abacus Junior Vet, automatic analyzer
Diatron Messtechnik, Budapest, Hungary. Blood chemistry (urea and creatinin) was measured
using screen point semiautomatic analyzer, STAT – FAX 1904 Plus, Global Medical
Instrumentation, Inc. 6511 Bunker Lake Blvd. Ramsey Minnesota, 55303 USA, by using
special determination kits in the Department of Pathophysiology, University of Agricultural
Science and Veterinary Medicine Cluj-Napoca.
The data were expressed as the mean and standard deviation. T Student multiple range
test from Excel Windows Software was used to assess the differences among groups.
Differences at p<0.05 and p<0.01 were considered significant and respectively distinct
significant.
RESULTS AND DISCUSSIONS
Body weight. Development of EAC was expectedly followed by a significant increasing
in body weight. Doxorubicin revealed a strong protective effect; in treated animals, the body
weight was slightly decreased. Even no so effective like Doxorubicin, alcoholic extracts
provides a protective effect, but statistical significance was found only for H. maculatum.
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Fig. 1. The variation on body weight among experimental groups (mean ± S.D.) (g)
Ascitic volume was highly decreased in Doxorubicin treated group; H. perforatum
provides more protection comparative to H. maculatum, but not statistically significant (Fig.
2). However, this cytostatic effect should not be excluded, at higher dosage. Important both
substances provide cytostatic effects, and no citotoxic ones, because tripan blue staining
revealed almost 100% viable cells in ascitic fluid. Plasma biochemistry, gross evaluation and
histopathological exam reveal no significant lesion for Hypericum maculatum and Hypericum
perforatum alcoholic extracts.
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Fig. 2 The ascitic volume (mean ± S.D.) (ml)
Alcoholic solutions inhibited the increase in body weight due to tumor burden when
compared to the EAC control group. Hence, it may be concluded that alcoholics tinctures of
H. maculatum and H. perforatum by decreasing the nutritional fluid volume and arresting the
tumor growth.
Red blood cells count (RBC) count and hematocrit (HCT), shown normal values only in
Doxorubicine treated groups and in HM group, in the others groups the values wore slightly
decreased without statistical significance. (Table 1)
White blood cells (WBC) were increase in Hypericum treated groups, more evident in
H. perforatum. The increasing of WBC level was done mainly on granulocytes. On EAC
inoculated animals, doxorubicin prevents the elevation of granulocytes levels, no similar
effect was found in Hypericum treated animals.
A decrease in hemoglobin and the number of erythrocytes and a significant increase in
total WBC (Table 1, 2) in the tumor-bearing mice are known. Anaemia is found frequently in
cancer patients (De Vita VT Jr et. all. 1993). Similar results were observed in the present
study.
Tab. 1.
The haematological profile (erythrocytes values) (mean ± S.D.)
RBC 1012/l HGB g/dl HCT % MCV fl MCH pg MCHC g/dl RDWs fl
EAC 6.48±1.21 9.46±1.95 28.73±5.63 44.20±3.35 14.56±0.83 33.00±1.61 42.06±5.26
EAC+
Doxo
7.04±0.90 11.75±1.60 35.99±4.67 51.00±1.82 16.72±0.48 32.70±0.36 37.30±1.92
EAC+
HP
6.36±0.63 10.87±0.90 30.34±1.95 47.85±2.61 17.16±1.24 34.81±1.67 34.08±2.31
EAC+
HM
6.70±0.88 10.70±1.20 31.28±4.04 46.71±1.80 16.02±0.75 34.27±0.77 33.27±1.98
HM 7.58±0.81 12.08±1.31 36.08±3.01 47.60±1.34 15.96±0.19* 33.50±0.98 33.79±1.04
HP 6.89±1.19 11.12±1.59 33.36±3.96 49.00±3.32 16.02±0.88* 33.24±0.83 35.46±1.88
Doxo 7.33±0.98 11.26±1.29 34.35±5.26 46.80±3.08 15.31±1.32 32.66±1.13 39.06±3.60*
M 6.67±1.40 10.26±2.22 31.74±6.05 47.78±2.11 15.34±0.59 32.13±1.025 34.03±4.03
Normal values: RBC 7-12.5*1012/l HGB 10.2-18 g/dl HCT  36-49 % MCV 53.6-56 fl
MCH 48.1-50 pg MCHC 31.3-33.2 g/dl (Uray, 1992)
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The Ehrlich Ascitic Tumor implantation induces per se a local inflammatory reaction,
with increasing vascular permeability, which results in an intense edema formation, cellular
migration, and a progressive ascitic fluid formation (Fecchio D. et. al 1990).
Tab. 2.
The leucogram (mean ± S.D.)
WBC 109/l LYM 109/l MID 109/l GRA 109/l
EAC 62.32±45.82 9.15±6.61 2.58±3.58 50.56±44.44
EAC + Doxo 15.01±9.46 8.93±3.014 0.34±0.39 5.64±6.37
EAC + HP 57.83±28.76 8.65±4.28 6.20±4.56 42.97±20.39
EAC + HM 22.92±16.29 5.40±4.00 1.19±0.92 16.32±12.28
HM 7.02±2.93 4.49±2.14 0.13±0.04 2.41±0.91***
HP 7.65±2.77* 3.80±1.46 0.29±0.19* 3.55±2.21**
Doxo 2.48±1.42** 1.74±0.94*** 0.11±0.10 0.64±0.49
M 4.87±1.83 4.29±1.69 0.11±0.07 0.45±0.26
Normal values WBC 6-15 109/l (Uray, 1992)
On the healthy animals as well as on tumor inoculated animals both alcoholic extracts
induces a significant increasing of the platelets as compared to control group that may suggest
an imunostimulatory effect (Table 3)
Tab. 3/
The platelets (mean ± S.D.)
PLT 109/l PCT % MPV fl PDWs fl
EAC 648.80±205.39 0.40±0.21 6.20±0.38 6.70±0.60
EAC + Doxo 498.50±110.03 0.32±0.08 6.38±0.31 6.40±0.24
EAC + HP 674.57±196.02 0.43±0.14 6.24±0.40 6.33±0.94
EAC + HM 757.00±287.97 0.49±0.20 6.41±0.32 6.44±0.59
HM 905.60±149.11*** 0.59±0.09*** 6.56±0.23 7.04±0.23
HP 941.60±302.34*** 0.68±0.19*** 7.36±0.72*** 8.78±1.76***
Doxo 643.70±190.93 0.38±0.11* 5.91±0.17 5.88±0.42
M 389.33±181.25 0.23±0.11 5.97±0.19 5.84±0.43
Normal values PLT 160-410 109/l (Uray, 1992)
*= statistically significant at p<0.05 as compared to Control group
**= statistically distinct significant at p<0.01 as compared to Control group
***= highly statistically significant at p<0.001 as compared to Control group
In previous studies on Hypericum spp. extracts, despite previous scientific rapports, no
antiproliferative effect in oral administration has been found (Prodan et all. 2009). However,
now, the intra peritoneal administration, proved to be far more effective against tumor cell
development, and, also, were able to induce hematological changes.
In the development of new cancer therapies, significant antitumor activity without
toxicity is the goal. In the case of plant-derived antitumor agents, an abundant supply of the
plant is also a prerequisite. St. John’s Wort appears to satisfy both criteria, as it grows
abundantly in Europe, North America, North Africa, and Asia, and has an excellent safety
profile with minimal side effects. Schempp et all. (2002) found hyperforin dose dependently
inhibited the growth in vitro of rat and human mammary cancer, as well as squamous cell
carcinoma, malignant melanoma, and lymphoma.
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CONCLUSIONS
In the actual study, both Hypericum sp. (H. maculatum and H. perforatum), have shown
anticancer effect, through inhibition of tumor cells development and elevating the white blood
cells level. The antitumor effectiveness of H. perforatum is already well documented, but
remarkably H. maculatum was not only effective, but it was even more active than H.
perforatum. This might be the basis of new pharmaceutical remedies using H.maculatum a
wide spread species in mountain regions of Romania.
Acknowledgments. This study has supported by National Centrum for Projects Management
(CNMP) as part of Contract no. 61-005 /14.09.2007.
REFERENCES
1. Ciulei I., E. Grogorescu, U Stănescu, (1993) Plante medicinale, Vol. I, Ed. Medicală, Bucureşti,
pag. 526-553.
2. De Vita VT Jr, S Hellman, SA. Rosenberg (1993). Cancer: principle and practice of oncology, 4th
ed. Philadelphia: J.B. Lippincott Company.
3. Fecchio D, P Sirois, M Russo, S Janear.(1990) Studies on inflammatory response induced by
Ehrlich tumor in mice peritoneal cavity Inflammation.14:125–131.
4. Herman G.H., A. Gheorgiu, (1961), Contribuţii la studiul valorificării plantei Hypericum
perforatum, Farmacia, 9 (4), pag. 227-230.
5. Istudor Viorica, (1998) Farmacognozie, vol. I, Ed. Medicală, Bucureşti, pag. 233-235.
6. Marcus I., A.I. Baba, D. Borda, C. Bele, S. Andrei, A. Pintea, Al. Pop, B. Sevastre, (1998),
Clinical and paraclinical aspects correlated with biological behavior of Ehrlich tumour grafted im
and sc at laboratory animals. Buletin USAMV -CN, 2: 545-553.
7. Olinescu A., (1992), Ehrlich ascitic tumour, experimental model. Biology of the laboratory animal
and comparative oncology. Oncology Institute, Cluj Napoca vol 19 (in Romanian).
8. Prodan Iulia, B. Sevastre, Ana-Maria Toiu, Daniela Benedec, Ilioara Oniga, C. Deliu, I. Marcus.
(2009), Antitumour activity of Hypericum Perforatum L. and Hypericum Maculatum C. in Ehrlich
Ascitic Carcinoma, Buletin USAMV-CN, nr.66 (1-2)
9. Schempp CM, V. Kirkin, B. Simon-Haarhaus, et al.(2002) Inhibition of tumour cell growth by
hyperforin, a novel anticancer drug from St. John’s wort that acts by induction of apoptosis.
Oncogene;21:1242-1250.
10. Sevastre B., F. Lucian, Iulia Prodan, I. Marcus, M. Tamas and C. Deliu, (2008), Peucedanum
oreoselinum Moench effect in Ehrlich ascitic carcinoma, Bulletin USAMV-CN -CN; 65: - . ISSN
1454-2382.
11. Stănescu Ursula, Monica Hăncianu, Anca Miron, Clara Aprotosoaie, (2004), Plante medicinale de
la A la Z, Ed. Gr.T. Popa UMF Iaşi, vol. II, pag. 297-305.
12. Tămaş M., C. Drăgulescu, I. Oniga, F Gliga, (2001), Comparative Chemical Research on some
Hypericum species and Hypericum perforatum L. populations from Sibiu County flora, Acta
Oecologica, 8 (1-2), pag. 25-33.
13. Uray Z. (1992), Hanbook of biologica and physiological data in laboratory animals. Biology of the
laboratory animal and comparative oncology. Oncology Institute, Cluj Napoca vol 19 (in
Romanian).
14. X X X, (2008), European Pharmacopoeia – Supl. 2001”, pag. 972-973, Council of Europe
Strasbourg, Ed., pag. 2958-2959.
15. X X X, (1993), Farmacopeea Română, Ed. X, Ed. Medicală, Bucureşti, pag. 483-484.
16. X X X, (2002), World Health Organization Monographs on selected Medicinal Plants, Geneva,
pag. 149-171.
17. York H., W. Funk, H. Fischer, (1990), Thin-layer Chromatography, VCH verl. Weinheim, vol I,
pag. 277-280.
